Cytokinetics Shares Surge Following Sanofi's Acquisition of Rights
Daily NewsInvesting.com -- Cytokinetics, Incorporated (NASDAQ:CYTK) shares rose 4.8% after the company announced that Sanofi would acquire exclusive rights to develop and c...
Read More